儿科质瘤中的表观遗传重编程:从分子机制到治疗含义
Santiago Haase1, Stephen Carney1, Maria Luisa Varela1
1Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, Biomedical Science Research Building, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Biointerfaces Institute, BioInnovations in Brain Cancer Initiative (BIBC), University of Michigan, Ann Arbor, MI, 48109, USA.
Trends in cancer
|October 11, 2024
概括
儿童和成人脑瘤的结果不同. 年轻质瘤中染色质调节者的突变重新连接染色质景观,影响基因表达,并通过表观遗传失调驱动癌症.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 儿科和成人脑瘤表现出不同的临床行为和治疗反应.
- 在儿科和年轻成年人质瘤中,组织蛋白和染色质调节者的反复突变很普遍.
- 这些突变表明染色体格局的重新连接,以促进致癌计划.
研究的目的:
- 审查质瘤亚型中的染色质景观变化如何影响瘤特征.
- 探索表观遗传失调对细胞命运,增殖,免疫格局和辐射抵抗的影响.
- 突出开发向表观遗传疗法的影响.
主要方法:
- 关于儿童和成人质瘤染色体调节的科学文献的综述.
- 分析基因组转化后修饰 (PTMs) 和染色质可访问性的作用.
- 检查表观遗传变化如何影响基因转录和瘤性途径.
主要成果:
- 染色体调节者的早期体质突变导致基因组位点的调节失调.
- 变化的基因组PTM和染色质可访问性导致基因组代码的变化.
- 质瘤亚型中明显的染色质失衡会影响细胞命运,增殖,免疫逃避和辐射抵抗.
结论:
- 表观遗传失调,特别是在染色质中,是儿科和年轻成人质瘤的关键驱动因素.
- 了解这些表观遗传机制对于推进向表观遗传疗法至关重要.
- 向染色体失衡为质瘤治疗提供了一个有前途的治疗策略.
相关概念视频
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K


